Is Taiwan Semiconductor a Better Buy Than Intel for 2026?

Taiwan Semiconductor (TSMC) reported $121.3 billion in revenue for 2025, up 37% year-over-year and a three-year revenue CAGR of 20.48%, with industry-leading profitability (gross margin 58.98%, net margin 43.29%) and a trailing-12-month diluted EPS of $1.99. TSMC holds $90.25 billion in cash against $33.76 billion of debt (net cash ~$56.5 billion), pays a 0.99% dividend with a five-year dividend CAGR of 12.3%, and has seen its stock rise ~66% over the past year; by contrast Intel’s revenue has declined (three-year avg -8.4%), gross margin is ~33%, net margin ~0.37%, TTM EPS ~$0.05, cash ~$30.94 billion, debt ~$46.55 billion (net debt ~ $15 billion) and its dividend was suspended in late 2024. The piece emphasizes TSMC’s dominant role in global advanced-chip supply (estimated 60% of global production, 90% of most advanced nodes) and its U.S. manufacturing expansion (including a large Arizona facility and additional land acquisitions), arguing TSMC is the superior semiconductor investment versus Intel.

Analysis

Market structure: TSMC (TSM) sits at the top of a concentrated foundry oligopoly (≈60% total, ≈90% advanced nodes) giving it durable pricing power and capex scale advantages versus IDMs like Intel (INTC). Customers building AI stacks (NVDA exposure) intensify demand for leading-node wafers; expect structural tightness in 5nm–2nm capacity for 12–36 months supporting mid-20%+ revenue CAGR scenarios for TSM under normal demand.

Risk assessment: Biggest tail risks are geopolitical (PLA-Taiwan escalation), equipment chokepoints (ASML EUV delivery delays), and export-control regime shifts; any of these could compress TSM market cap by 20–50% in days. Time horizons matter: news-driven moves in days/weeks, capacity and margin shifts over quarters (3–12 months), and node leadership outcomes over years (2–5 years). Hidden dependencies include customer concentration (top 5 customers >40% rev) and utilities (water/energy) in Taiwan.

Trade implications: Tactical trades favor long TSM and overweight foundry/equipment names, underweight legacy x86 incumbents (INTC). Options: LEAP calls on TSM (18–36 months) to capture secular upside; short-dated put spreads on INTC to express downside while limiting cash outlay. Entry: stagger 50/50 now and on any TSM pullback ≥5%; take profits if TSM total return >40% or if gross margin falls >500bps.

Contrarian angles: Consensus underprices Intel’s optionality from CHIPS Act-funded capacity and potential turnaround—small asymmetric bets (e.g., cheap INTC calls) make sense. Conversely, the market may underprice a Taiwan geopolitical tax; size TSM exposure assuming a 10–20% probability of severe disruption and hedge accordingly. Overinvestment risk: aggressive U.S. fabs could inflate TSM capex/S&A and compress margins by 200–400bps over 2–3 years.

Key Decisions for Investors

• Establish a 3–5% portfolio long position in TSM (buy NYSE:TSM) using DCA: 50% immediately, 50% on any pullback ≥5%; concurrently buy 1-year 20% OTM put protection sized to 25% of notional to cap downside; target hold 12–36 months, trim half at +40% total return or if gross margin drops >500bps.
• Initiate a relative-value pair trade: long TSM (2% portfolio) and short INTC (1–2% portfolio) to be dollar-neutral; set stop-loss if spread narrows by 15% and take profit if spread widens by 30% within 12 months.
• Buy TSM Jan 2028 LEAP calls (delta ~0.6) sized 1–2% notional to capture secular node leadership; if premium >5% of portfolio, convert to a 12–18 month 10%/30% call spread to control cost.
• Allocate 1% portfolio to a cheap asymmetric INTC recovery ticket: buy 12-month 200%/300% OTM call spread (low cost) to capture binary turnaround upside funded from reduced legacy semiconductor holdings; exit if INTC EPS trajectory turns positive two consecutive quarters.
• Risk-trigger rule: monitor US export-control announcements and any PLA military escalation signals over next 30–90 days—if a new restriction materially limits TSM-China shipments or a Tier-1 kinetic event occurs, reduce TSM exposure by 50% within 48 hours and redeploy into US-based foundry/equipment names or short-term Treasuries.